Clinical trial
Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After…
NCT00290212 · University Hospital of North Norway, Other · Completed
Key facts
| NCT number | NCT00290212 |
|---|---|
| Title | Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause |
| Official title | Phase II Study of Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause: a Randomised Double Blind Placebo-Controlled Trial |
| Lead sponsor | University Hospital of North Norway, Other |
| Collaborators | University of Tromso The International Osteoporosis Foundation Haukeland University Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Perimenopausal Bone Loss |
| Intervention type | Drug |
| Interventions | Natto capsules (food suppl.) cont. 360 microg. vit K2/day, Placebo capsules |
| Enrollment | 304 |
| Start date | Jan 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Feb 10, 2006 |
| Last update posted | Jan 24, 2008 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: